Medium Biosciences

AI-designed Affinity Reagents

HealthcareDiagnosticsArtificial IntelligenceMachine LearningBiotech http://medium.bio ↗

Company facts

Early-stage
Founded
2021
Employees
6
Headquarters
United States

About

We turn advances in AI and protein design into experimentally validated molecular tools, partnering with research teams and diagnostic developers to deliver high-performance affinity reagents in weeks, not months.